Who We Are
History
From a regional pharmaceutical market in 1984
To a leading international pharmaceutical company,
generating revenue of around L.E. 2.6 Billion in 2022.
MUP started as a small business in 1984 by launching 5 products.
Then the 1st conventional plant was established in Abu-Sultan (Ismailia), since then, MUP has grown significantly in Egypt, Middle East and Africa.
Over the last 3 decades, MUP has introduced 2 more factories; Penicillin & Cephalosporin in addition to acquiring Eli-Lilly’s insulin factory “Only insulin factory in middle east
1984 - 1990
Dr. Salah Ramadan
Chairman & CEO
1984 - 1989
MUP was founded and the 1st conventional plant in Abu Sultan – Ismailia-Egypt was established.
1989 - 1990
Launched stepping-stones; Ranitidine. Mucosol, Miconaz, Rifactine and Sorbit.
1991 - 2011
Dr. Zakaria Gad
Chairman & CEO
1991 - 2000
Launched Streptoquin, Dispercam, GR6, Zinc Olive, Night & Day, Hi-Cal, Bebe-vit, Vidrop, Laxolac and Mobitil.
2001 - 2007
Penicillin era, MUP launched blockbuster antibiotic Unictam.
Anti-Diabetic era, launched Dolcyl.
Cephalosporin era, launched Xorin.
2008 - 2011
CVS era, launched Lipinorm & Irbedrin.
Started Cephalosporin and Penicillin new factories projects.
Started Cephalosporin and Penicillin new factories projects.
2012 - 2016
Dr. Mohamed Abd El-Gawad
Chairman
Dr. Ahmed Kelani
CEO
2013
Cephalosporin and Penicillin factories started production, and since then, MUP joined the top leading companies in antibiotics to become the “House of Antibiotics” in Egypt.
2014
MUP became the First Egyptian company to acquire Eli-Lilly's Insulin factory in Egypt; the only Insulin multinational facility in the MENA region.
2015
Biological medicine era, Launched Insulinagypt.
2016 - 2018
Dr. Ahmed Kelani
Chairman & CEO
2016-2017
Launched Spectracef, Fortazedim.
2018
Launched Normifrin nasal spray.
2019 - 2022
Dr. Awad Gabr
Chairman & CEO
2019
Launched Silverburn.
2020
Expansion of Warehouses capacity for APIs & Finished products in Penicillin and Cephalosporin plants.
2022 - Present
Prof. Dr. Ahmed Lila
Chairman & CEO
2022
Start running L.V.P, S.V.P and Insulin Cartridge projects.
Launched Davalindi (vit. d3) new range; 5000 I.U., 10,000 I.U., 200,000 I.U. Ampoule.
Launched Davalindi (vit. d3) new range; 5000 I.U., 10,000 I.U., 200,000 I.U. Ampoule.